You are here

Article Text

Article menu

Download PDFPDF

Anti-interleukin 5 strategies as a potential treatment for asthma.
Free
  1. A D Singh,
  2. C J Sanderson
  1. Department of Clinical Immunology, Liverpool Hospital, Sydney, NSW, Australia.

    Abstract

    A paradigm shift, championed largely by cellular immunologists, has redefined asthma as an immune mediated phenomenon characterised by an interleukin 5 (IL-5) driven eosinophilic bronchitis. This change in emphasis has provoked intense interest in the possibility that inhibitors of IL-5 production, or antagonists of its activity, will provide a new generation of anti-asthma drugs.

    http://dx.doi.org/10.1136/thx.52.5.483

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.